Also called: Trulicity (dulaglutide), LY2189265, AWARD
Dulaglutide is a medicine known by the brand name Trulicity. It belongs to a group of drugs that copy a natural body signal called GLP-1, which helps control blood sugar. It is mostly used by adults with type 2 diabetes, a condition where the body has trouble managing sugar in the blood. It is given as a shot, usually once a week. Dulaglutide helps the body release insulin, which lowers blood sugar, and it also tends to help with weight loss.
New research suggests it may help with other health problems too. One big study found that people with lung conditions like asthma or COPD (a serious breathing disease) who took dulaglutide for diabetes had fewer breathing flare-ups. Another large study looked at people with bipolar disorder, a mental health condition, who also had diabetes. It found this group of medicines did not seem to cause mental health harms, which is a good safety sign. There is still a lot to learn.
The breathing study mainly highlighted semaglutide as having the strongest effect, and dulaglutide's benefits for lungs need more proof. The mental health study focused on semaglutide, so dulaglutide's role there is not fully clear. Dulaglutide is an approved prescription medicine, but it can cause side effects like stomach upset. Anyone thinking about using it should talk to a doctor first, because it is a strong drug that needs proper medical care.
Benefits
The benefits people report — backed by research.
You just read the research on Dulaglutide. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Evidence
Every claim above traces back to a source you can check — here are 1 of them.
News
Dated, sourced reporting that mentions Dulaglutide.
An abstract presented at the 2026 European Respiratory Society International Congress links semaglutide use in patients with type 2 diabetes to fewer exacerbations in asthma (38% reduction) and COPD (21% reduction). Other GLP-1 receptor agonists like exenatide and dulaglutide also showed exacerbation reductions. The associations persisted regardless of weight or glycemic changes, suggesting possible direct lung anti-inflammatory effects.
A 440-patient phase 3 trial found Innovent's dulaglutide biosimilar LY05008 statistically equivalent to Trulicity for blood-sugar control in type 2 diabetes: HbA1c fell 1.44% versus 1.41% at 24 weeks, with similar safety and only about a quarter the hypoglycemia rate. With Trulicity's patent cliff behind it, results like this are how a $6-billion-a-year GLP-1 gets its cheaper copies.
Wondering how Dulaglutide pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Compare
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.